BioMed Research International

BioMed Research International / 2009 / Article

Methodology Report | Open Access

Volume 2009 |Article ID 901079 | 7 pages |

Improved Coinfection with Amphotropic Pseudotyped Retroviral Vectors

Academic Editor: Gerald Schumann
Received02 Oct 2008
Revised08 Feb 2009
Accepted11 Mar 2009
Published25 May 2009


Amphotropic pseudotyped retroviral vectors have typically been used to infect target cells without prior concentration. Although this can yield high rates of infection, higher rates may be needed where highly efficient coinfection of two or more vectors is needed. In this investigation we used amphotropic retroviral vectors produced by the Plat-A cell line and studied coinfection rates using green and red fluorescent proteins (EGFP and dsRed2). Target cells were primary human fibroblasts (PHF) and 3T3 cells. Unconcentrated vector preparations produced a coinfection rate of 4% (defined as cells that are both red and green as a percentage of all cells infected). Optimized spinoculation, comprising centrifugation at 1200 g for 2 hours at , increased the coinfection rate to 10%. Concentration by centrifugation at 10,000 g or by flocculation using Polybrene increased the coinfection rate to 25%. Combining the two processes, concentration by Polybrene flocculation and optimized spinoculation, increased the coinfection rate to 35% (3T3) or 50% (PHF). Improved coinfection should be valuable in protocols that require high transduction by combinations of two or more retroviral vectors.

1. Introduction

High rates of infection of target cells with two or more retroviral vectors are often required to achieve a desired biological outcome. In particular, the production of induced pluripotent stem (iPS) cells requires a high rate of coinfection in order to obtain a sufficient fraction of cells that express all four reprogramming factors, OCT4, SOX2, KLF4, and c-MYC [1, 2]. Methods are needed to ensure that high coinfection rates are reliably achieved. When introducing reprogramming genes into human fibroblasts, Yamanaka's group used a complex strategy to increase coinfection to a rate sufficient for reprogramming. They first introduced the ecotropic retrovirus receptor into the target human cells using a lentiviral vector, and then infected the cells with retroviruses produced in the ecotropic Plat-E packaging cell line [2]. Plat-E and Plat-A cells are retrovirus packaging cell lines derived from the 293T cell line [3]. While other packaging cell lines used viral LTRs for expression of viral structural genes, Plat-E and Plat-A cells utilize the potent EF1α promoter in combination with a Kozak consensus sequence upstream of the initiation codon, resulting in high expression of viral structural proteins [3]. However, the Plat-A cell line, used for amphotropic pseudotyping, produces a titer of only about one-tenth that of the ecotropic packaging cell line Plat-E [4]. Titers from other amphotropic retrovirus packaging cell lines derived from 293T, such as Phoenix-Ampho, are similar [5]. Consistent with a lower rate of vector production by Plat-A than by Plat-E cells, Yamanaka's group showed that human fibroblasts infected with vector from Plat-E cells following introduction of the ecotropic retrovirus receptor were transduced at 3 times the rate of fibroblasts infected with vector from Plat-A cells [2].

In experiments involving coinfection to achieve cellular reprogramming unconcentrated retroviruses have been used. Generally, unconcentrated preparations produced by amphotropic packaging cells are sufficient for the introduction of single genes into cells. However, higher levels of vector are needed for efficient coinfection with two or more retroviruses. There has been little work on optimizing conditions for coinfection with amphotropic or ecotropic retroviral vectors. Although it may be assumed that any improvement in the rate of infection will increase the rate of coinfection, this has rarely been tested [6]. We hypothesized that the use of optimized protocols could result in much higher coinfection rates by amphotropic retroviral vectors produced by packaging cell lines like Plat-A.

Strategies for increasing the amount of amphotropic or ecotropic vector that can be delivered to target cells include (a) increasing vector production rates by the packaging cells [5], (b) concentrating the vector, and (c) increasing the rate or level of attachment of vector to the target cells. Amphotropic retroviruses can be concentrated by centrifugation, although some loss of titer may be encountered [7, 8]. Retroviruses pseudotyped with vesicular stomatis virus G (VSV-G) protein can readily be concentrated by centrifugation, but preparation of this type of vector typically requires cotransfection of 293T cells with multiple plasmids [9]. A convenient and efficient method for concentrating amphotropic retroviral vectors was introduced recently; this comprises flocculation of the vector with high concentrations of polymers such as Polybrene followed by a brief centrifugation [10, 11]. This process also separates active viral particles from inactive particles that can compete for receptors on target cells [12]. Polymers, usually Polybrene, are also used in standard infection protocols to increase attachment of viral vectors to target cells [13]. This is particularly effective in established cell lines in combination with low-speed centrifugation of the vector onto the surface of the target cells, a process termed spinoculation or spin-infection [8, 14]. This has not been extensively tested in primary human cell types, however. The two processes should be complementary: separation of the vector from the bulk medium by Polybrene flocculation can be followed by resuspension of the vector in culture medium and optimized infection of the target cells by spinoculation.

In the present experiments we tested whether amphotropic retroviral vectors can be concentrated and efficiently delivered to target cells (primary human fibroblasts and 3T3 cells) by spinoculation. Coinfection rates were determined by the use of retroviral vectors encoding two different fluorescent proteins, EGFP and dsRed2 [15]. We found that the combination of flocculation by Polybrene together with delivery of the precipitated retrovirus-Polybrene complex to target cells by spinoculation raised the coinfection rate by >10-fold over that observed using maximal volumes of unconcentrated viral vector.

2. Materials and Methods

2.1. Cell Culture

Plat-A amphotropic retrovirus packaging cells [3] were obtained from Cell Biolabs (San Diego, Calif, USA). Newborn human skin fibroblasts (CRL-2703, also termed CCD-1137sk) and Swiss mouse 3T3 cells were obtained from the American Type Culture Collection, Manassas, Va, USA. Cells were cultured in Dulbecco's Modified Eagle's Medium supplemented with 10% Cosmic Calf Serum (HyClone Laboratories, Logan, Utah, USA), 0.1 mg/ml penicillin and 0.05 mg/ml gentamicin (referred to here as complete culture medium). Plat-A cells were grown in medium that also contained 10  g/ml blasticidin and 1  g/ml puromycin [3].

2.2. Retroviral Vectors

A retroviral vector encoding EGFP (pLEGFP-N1) was obtained from Clontech, Palo Alto, Calif, USA. A retroviral vector encoding the red fluorescent protein dsRed2 was derived by cloning the dsRed2 coding region (Clontech) downstream of the LTR in plasmid pMXs [4] to form pMXs-dsRed2.

2.3. Viral Vector Production

Amphotropic retroviruses were generated by transient transfection of Plat-A cells. Plat-A cells were plated at per 6-cm dish (poly-L-lysine coated; BD Biosciences). The following day, the culture medium was replaced with fresh medium containing 25  M chloroquine and 10 mM sodium butyrate [16]. Immediately following this, cells were transfected with 10  g retroviral plasmid DNA using the calcium phosphate precipitation procedure [16]. After 16 hours the medium was changed to 3.5 mL fresh medium. After 24 hours the vector-containing medium was removed and filtered through a 0.45  m syringe filter. A second 24 hour medium collection was also used for infections.

For each experiment, a single pool of EGFP vector (“green vector”) from the Plat-Acells was combined with a single pool of dsRed2 vector (“red vector”). We investigated whether the titers of the green and red vectors used were equivalent when tested on target cells, PHF or 3T3. In each experiment reported here the titers were approximately equal.

2.4. Infection of Target Cells

CRL-2703 cells or 3T3 cells were plated in 6-well plates (BD Biosciences) ( 10 cells per well). Infection was begun when cells were dividing maximally at 60–70% confluence. Viral vector-containing medium (3.5 ml EGFP vector plus 3.5 ml dsRed2 vector) was added to cells with the addition of 8  g/ml Polybrene [hexadimethrine bromide (Sigma), usually referred to by the trademarked name Polybrene]. After 4 hours, 50% of the medium was replaced with fresh medium. The next day cells were infected a second time using the same procedure. Following this, cells were grown in regular complete medium.

2.5. Spinoculation

For spinoculation, vector-containing medium (3.5 ml EGFP vector plus 3.5 ml dsRed2 vector) was added to the target cells with addition of Polybrene. Plates were wrapped in Parafilm to minimize pH changes resulting from loss of from the medium. Plates were transferred to a plate carrier and centrifuged using a Beckman JS-4.3 swinging bucket rotor for 2 hours at different temperatures and speeds (see Section 3). Following centrifugation, plates were returned to the incubator. Subsequently, either 50% of the medium was replaced with fresh medium after 2 hours, or 100% was replaced after 4 hours (see Section 3). The following day the spinoculation procedure was repeated. Following this, cells were grown in regular complete medium.

2.6. Viral Vector Concentration by Centrifugation

Equal volumes of medium containing EGFP and dsRed2 vectors, of approximately equal titers, were mixed and centrifuged at 10000 g for 3 hours at [7, 8]. Volumes of vector-containing medium used were equal to those from either 3 or 16 plates of EGFP- and dsRed2-transfected Plat-A cells (see Section 3). Green and red vectors were mixed before centrifugation. The pellet (usually not visible) was resuspended in 7 ml complete culture medium and added to target cells with Polybrene. The following day, medium was changed with addition of the same amount of concentrated vector. Following this, cells were grown in regular complete medium.

2.7. Viral Vector Concentration by Flocculation with Polybrene

Polybrene (320  g/ml) was added to vector-containing medium of a volume equal to that from 16 plates of EGFP- and dsRed2-transfected Plat-A cells. Green and red viruses were mixed together. The medium was incubated at for 20 minutes followed by centrifugation at 10,000 g for 10 minutes at [10]. The pellets were combined into complete culture medium to a final volume of 7 ml which was added to the target cells. The following day, medium was changed with addition of the same amount of concentrated vector. Following this, cells were grown in regular complete medium.

2.8. Combining Flocculation with Polybrene and Spinoculation

For the combination of concentrating the vector together with spinoculation, viral pellets were resuspended in 7 ml complete culture medium for transfer to target cells, which were subjected to the spinoculation procedure described above (1200 g at for 2 hours). This was repeated the following day. Following this, cells were grown in regular complete medium.

2.9. Determination of Coinfection Rate

The two retroviral vectors used encode fluorescent proteins, EGFP and dsRed2, enabling detection of transduced cells by fluorescence microscopy. At 4 days following infection, photographs of random fields of cells were obtained using a 12-bit CCD camera attached to a Zeiss Axiovert microscope. Three images were obtained for each cell field: a phase-contrast image, a “red" image and a “green" image (the latter two images are gray-scale images obtained using appropriate specific filters for EGFP and dsRed2). Each cell that was scored as positive in the red image was located on the phase-contrast image and marked as such. The process was repeated separately for the green image. This results in two copies of the phase-contrast image, one with green cells marked and the other with red cells marked. We then made three totals, those cells that are red but not green, those that are green but not red, and those that are both red and green. The percentage coinfection were determined as [Number of cells that are both green and red]/[Number of cells that are either green or red] . In coinfection experiments, each procedure was performed in triplicate. Data are presented as averages and standard deviations. Statistical analysis was carried out by one-way ANOVA and post hoc analysis by the Neuman-Keuls multiple comparison test (Prism software, GraphPad Software, San Diego, Calif, USA).

3. Results

We tested whether spinoculation is a suitable procedure for increasing infection of PHF by amphotropic pseudotyped retrovirus produced by Plat-A cells. In preliminary tests using literature protocols [14] we found that low-speed centrifugation at or above was detrimental to PHF cell viability. We tested spinoculation at lower temperatures and found that infection was increased by 5-fold when cells were centrifuged at 1200 g for 2 hours at , whereas it was increased 4-fold at . Because of the apparent susceptility of PHF to damage by spinoculation at room temperature, we also investigated whether a lower speed (600 g) might be more effective than conventional speeds (≥1200 g). We found that spinoculation at 600 g for 2 hours at increased infection ( 3-fold over no spinoculation control) but was less effective than higher speeds. Additionally, we found that 1200 g, 2400 g and 4200 g (2 hours at in each case) produced similar increases over the no spinoculation control. In Figure 1, we show an example of the increase in infection in PHF when spinoculation was used at 600 g and 2400 g. We decided to use 1200 g, as a standard protocol because speeds >1200 g gave results similar to 1200 g, and thus it was unnecessary to use higher speeds. In repeated experiments, spinoculation of PHF at 1200 g for 2 hours at resulted in increases in infection in the range of 5- to 10-fold.

Having confirmed that spinoculation is a suitable method for infecting PHF with vector produced by Plat-A cells, we then combined optimized spinoculation with vector concentration. Because our aim was to improve coinfection, we measured coinfection rates for unconcentrated vector, spinoculation, vector concentrated by ultracentrifugation or Polybrene flocculation, and the combination of spinoculation and concentration. To measure coinfection rates, cells were infected with a 1 : 1 mixture of retroviruses encoding green (EGFP) and red (dsRed2) fluorescent proteins of approximately equal titers. Representative fields of infected cells are shown in Figure 2. Merged green and red images reveal the coinfected cells. It was noticeable that relatively few cells were coinfected with unconcentrated vector, despite the fact that there were many cells that had been infected with either the green or the red vector. Images of cells infected by spinoculation or with vector concentrated by Polybrene flocculation show greater numbers of coinfected cells. However, the combination of concentration and spinoculation produced an obvious and dramatic increase in coinfection rates (Figure 2).

Using a protocol described in detail in Section 2, the increase in coinfection rates with spinoculation and concentration was assessed as the number of cells that are both green and red as a percentage of the cells that are either green or red (i.e., coinfected cells as a percentage of infected cells). These values varied from a low of 4% for unconcentrated vector to >50% for the combination of concentration by Polybrene flocculation and spinoculation (Figure 3). We confirmed, as found by others, that concentrating amphotropic retroviruses by centrifugation is feasible. When a single retroviral vector was used, concentrating the vector from medium equivalent to that from 3 or 16 Plat-A plates resulted in approximately the expected increase in infection of target cells (either HDF or 3T3). When we tested coinfection, vector that had been concentrated from a volume of medium equivalent to that from 3 plates of green vector and 3 plates of red vector resulted in a small increase in coinfection over unconcentrated vector, while concentrating vector from 16 sets of plates increased coinfection to 25%. We found comparable values for coinfection using vector concentrated by centrifugation alone (10,000 g for 3 hours) and for vector concentrated by Polybrene flocculation. Because Polybrene flocculation is much faster ( 30 minutes versus 3 hours) this method is preferable. When Polybrene flocculation was combined with spinoculation, the coinfection rate increased to 53%. This was a significant increase over either concentration alone or spinoculation alone.

To determine whether the results in PHF were reproducible in another cell type, the effects of spinoculation and Polybrene flocculation were tested on coinfection rates in Swiss mouse 3T3 cells. Results were very comparable to those in PHF (Figure 3). Both spinoculation and Polybrene flocculation resulted in increased coinfection, while the combination of Polybrene flocculation and spinoculation resulted in a coinfection rate of 35%. This was significantly more than either spinoculation or Polybrene flocculation alone.

4. Discussion

While high rates of coinfection are needed for efficient delivery of genes to target cells, for example for iPS cell production, few studies have been performed with the aim of improving coinfection rates with retroviral vectors. Here we combined two protocols, spinoculation and concentration, with the result that coinfection of HDF improved from 4% to >50%. Concentration of amphotropic retroviral vectors can be performed by 10,000 g centrifugation or by Polybrene flocculation, but the latter is preferred because of its rapidity. In these experiments we investigated coinfection by a mixture of two viral vectors. As the number of different types of retroviral vectors in a mixture increases, cells that have been infected with all the viral types in the mixture become increasingly infrequent, thus emphasizing the necessity for optimizing coinfection conditions.

In the context of human iPS cell generation, coinfection rates for viruses encoding the four reprogramming factors were not measured. Yamanaka's group reported a rate of human iPS cell generation of 10 colonies per 50,000 starting cells together with 100 non-iPS-like colonies; when c-MYC was omitted, far fewer non-iPS-like colonies were generated, and 0-5 iPS colonies arose from a population of 500,000 cells [2]. The importance of a high rate of coinfection was also shown recently by another group, who initially reported that four reprogramming factors were insufficient for iPS cell generation from adult human fibroblasts [17]. When a sufficiently high retroviral multiplicity of infection was employed, the other factors were not needed [18]. Another consideration is that it may be necessary to achieve infection rates high enough not only to deliver four reprogramming factors efficiently but also to produce multiple integrations of each viral genome in target cells [1, 2, 1922]. This is unlikely to represent a requirement for insertional mutagenesis; probably, only cells with multiple integrations achieve levels of expression of the reprogramming factors that are high enough for iPS cell generation.

Recent results show that iPS cell generation is possible with one or two transcription factors in combination with small molecules that induce reprogramming [23]. For the immediate future, generation of iPS cells may use combinations of viral methods, which require high efficiency coinfection, together with other innovative techniques. The application of the relatively simple methods described here to increase coinfection should be useful for iPS cell generation and for other experiments in which high coinfection rates are required.


This work was supported by grants from the National Institute on Aging, from the Owens Medical Foundation, and from the Glenn Foundation for Medical Research.


  1. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at: Publisher Site | Google Scholar
  2. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at: Publisher Site | Google Scholar
  3. S. Morita, T. Kojima, and T. Kitamura, “Plat-E: an efficient and stable system for transient packaging of retroviruses,” Gene Therapy, vol. 7, no. 12, pp. 1063–1066, 2000. View at: Publisher Site | Google Scholar
  4. T. Kitamura, Y. Koshino, F. Shibata et al., “Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics,” Experimental Hematology, vol. 31, no. 11, pp. 1007–1014, 2003. View at: Publisher Site | Google Scholar
  5. S. Swift, J. Lorens, P. Achacoso, and G. P. Nolan, “Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems,” in Current Protocols in Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Eds., pp. 10.17.14–10.17.29, John Wiley & Sons, New York, NY, USA, 1999. View at: Google Scholar
  6. S. Wotherspoon, A. Dolnikov, G. Symonds, and R. Nordon, “Susceptibility of cell populations to transduction by retroviral vectors,” Journal of Virology, vol. 78, no. 10, pp. 5097–5102, 2004. View at: Publisher Site | Google Scholar
  7. N. E. Bowles, R. C. Eisensmith, R. Mohuiddin, M. Pyron, and S. L. C. Woo, “A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo,” Human Gene Therapy, vol. 7, no. 14, pp. 1735–1742, 1996. View at: Publisher Site | Google Scholar
  8. B. L. Strang, Y. Ikeda, F.-L. Cosset, M. K. L. Collins, and Y. Takeuchi, “Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells,” Gene Therapy, vol. 11, no. 7, pp. 591–598, 2004. View at: Publisher Site | Google Scholar
  9. J. C. Burns, T. Friedmann, W. Driever, M. Burrascano, and J.-K. Yee, “Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 8033–8037, 1993. View at: Publisher Site | Google Scholar
  10. N. Landázuri, M. Gupta, and J. M. Le Doux, “Rapid concentration and purification of retrovirus by flocculation with Polybrene,” Journal of Biotechnology, vol. 125, no. 4, pp. 529–539, 2006. View at: Publisher Site | Google Scholar
  11. N. Landázuri and J. M. Le Doux, “Complexation with chondroitin sulfate C and polybrene rapidly purifies retrovirus from inhibitors of transduction and substantially enhances gene transfer,” Biotechnology and Bioengineering, vol. 93, no. 1, pp. 146–158, 2006. View at: Publisher Site | Google Scholar
  12. N. Landázuri and J. M. Le Doux, “Amphotropic retrovirus transduction is inhibited by high doses of particle-associated envelope proteins,” Biotechnology and Bioengineering, vol. 99, no. 5, pp. 1205–1215, 2008. View at: Publisher Site | Google Scholar
  13. K. Toyoshima and P. K. Vogt, “Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions,” Virology, vol. 38, no. 3, pp. 414–426, 1969. View at: Publisher Site | Google Scholar
  14. A. B. Bahnsonz, J. T. Dunigan, B. E. Baysal et al., “Centrifugal enhancement of retroviral mediated gene transfer,” Journal of Virological Methods, vol. 54, no. 2-3, pp. 131–143, 1995. View at: Publisher Site | Google Scholar
  15. C. G. Bailey and J. E. J. Rasko, “Autofluorescent proteins for flow cytometry,” Methods in Molecular Biology, vol. 411, pp. 99–110, 2007. View at: Publisher Site | Google Scholar
  16. W. Pear, “Transient transfection methods for preparation of high-titer retroviral supernatants,” in Current Protocols in Molecular Biology, F. M. Ausubel, R. Brent, R. E. Kingston et al., Eds., pp. 9.11.1–9.11.18, John Wiley & Sons, New York, NY, USA, 1996. View at: Google Scholar
  17. I.-H. Park, R. Zhao, J. A. West et al., “Reprogramming of human somatic cells to pluripotency with defined factors,” Nature, vol. 451, no. 7175, pp. 141–146, 2008. View at: Publisher Site | Google Scholar
  18. I.-H. Park, N. Arora, H. Huo et al., “Disease-specific induced pluripotent stem cells,” Cell, vol. 134, no. 5, pp. 877–886, 2008. View at: Publisher Site | Google Scholar
  19. N. Maherali, R. Sridharan, W. Xie et al., “Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution,” Cell Stem Cell, vol. 1, no. 1, pp. 55–70, 2007. View at: Publisher Site | Google Scholar
  20. H. Masaki, T. Ishikawa, S. Takahashi et al., “Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture,” Stem Cell Research, vol. 1, no. 2, pp. 105–115, 2007. View at: Publisher Site | Google Scholar
  21. K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007. View at: Publisher Site | Google Scholar
  22. M. Wernig, A. Meissner, R. Foreman et al., “In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state,” Nature, vol. 448, no. 7151, pp. 318–324, 2007. View at: Publisher Site | Google Scholar
  23. Y. Shi, C. Desponts, J. T. Do, H. S. Hahm, H. R. Schöler, and S. Ding, “Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds,” Cell Stem Cell, vol. 3, no. 5, pp. 568–574, 2008. View at: Publisher Site | Google Scholar

Copyright © 2009 Yuehong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

2181 Views | 689 Downloads | 9 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.